Standing Order
Moderna, Inc.

Dashboard

Moderna, Inc.

MRNANASDAQ

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$21B
Price$54.0752w $22.36 – $81.80
Conviction3/ 5
Revenue (TTM)$2.2B
Revenue growth YoY-29.1%
P/E (trailing)—
Gross margin-13.9%
Operating margin-153.3%
Net margin-143.6%
52w price change+99.9%
Next earningsJul 31, 2026

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

  • Jul 16
    Ownership changeSEC

    Form 4 insider transaction filing for MRNA.

  • Jul 10
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jul 8
    LeadershipSEC

    8-K filing (items 5.02,7.01,9.01) disclosing officer or director changes.

  • Jul 7
    Ownership changeSEC

    Form 4 insider transaction filing

  • Jul 6
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Jun 17
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jun 8
    Ownership changeSEC

    Form 4 insider transaction filing

  • Jun 8
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jun 3
    Ownership changeSEC

    Form 4 insider ownership change filing.

  • Jun 3
    Ownership changeSEC

    SEC Form 4 insider ownership change filing.

  • Jun 3
    Ownership changeSEC

    Form 4 insider transaction filing.

  • May 29
    OtherSEC

    SEC Form 4 insider beneficial ownership filing.

  • May 29
    OtherSEC

    SEC Form 4 filing reporting change in beneficial ownership by insider.

  • May 29
    OtherSEC

    Form 4 insider beneficial ownership change filing.

  • May 22
    OtherSEC

    Form 4 insider beneficial ownership filing submitted.

  • May 22
    OtherClinicalTrials.gov

    Vertex updates NCT05668741 (VX-522 Phase 1/2 CF trial) status to ACTIVE_NOT_RECRUITING

  • May 18
    OtherSEC

    SEC Form 4 insider beneficial ownership filing.

  • May 11
    OtherSEC

    8-K filing reports bylaw amendments (5.03) and shareholder vote results (5.07).

  • May 8
    OtherSEC

    SEC Form 4 insider beneficial ownership filing.

  • May 8
    OtherSEC

    Form 4 insider ownership change filing for MRNA.

Not financial advice — research and opinion only. Disclosures